This live facilitated two-part course provides clinicians the knowledge and confidence to prescribe gender affirming hormone therapy (GAHT) based on the needs of their patient population utilising an informed consent model. Additionally, supporting clinicians to create a gender affirming practice and establishing a business model for ongoing financial sustainability.
Date, Time, Platform:
- Dates:
- Part 1: Tuesday, 5 May 2026
- Part 2: Wednesday, 6 May 2026
- Time:
- NSW, QLD, VIC, ACT, TAS: 6:30pm – 8:30pm AEST
- SA, NT: 6:00pm – 8:00pm (ACST)
- WA: 4:30pm – 6:30pm (AWST)
- Platform: Online via Zoom
Presenters:
- Speakers:
- Adjunct Prof Darren Russell (he/his) | Sexual Health Physician | Prism Health and Kardinia Health, Geelong
- Zac Cannell (he/they) | Mental Health Clinician, LGBTQIA+ Health Educator and Advocate, Person of Trans Lived Experience.
- Facilitators:
- Victoria Featherstone (she/her) | GP | Holdsworth House
- Maggie Smith (she/they) | Nurse Practitioner | The Albion Centre
- Araz Ahmed (he/they) | Organisational Change Social Worker | Legal Aid NSW
- Margot London (she/her) | Community Health Promotion Officer- Trans Health Equity | ACON
Learning Outcomes:
- Identify the diverse needs of the Trans and Gender Diverse community
- Recommend gender affirming care to meet client needs and achieve desired outcomes.
- Assess and manage gender affirming care in the context of reproductive health.
- Implement gender affirming care utilising an informed consent model.
- Implement practical strategies to embed gender affirming care into practice.
Course Components:
- Mandatory pre-course learning modules:
- Attendance to both two-hour live facilitated online training sessions.
- Competency assessment.
Recommended Resources:
- Recommended further learning: Click here to watch “What Are Pronouns?”
CPD & Endorsement:
- This is a CPD Accredited Activity for 2.5 Educational Activity and 2 Reviewing Performance hours under the RACGP CPD Program for the 2026-2028 triennium. It is also accredited for 4.5 PDP hours under the ACRRM 2026-2028 triennium.
Funding:
This course received funding from the Australian Government Department of Health, Disability and Ageing.
Target Audience:
Clinicians currently or seeking to prescribe GAHT.